These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 25007525)
1. [Renoprotective efficacy of different doses of statins in experimental acute renal failure]. Zeleniuk VH; Zamors'kyĭ II; Horoshko OM Fiziol Zh (1994); 2014; 60(2):75-81. PubMed ID: 25007525 [TBL] [Abstract][Full Text] [Related]
2. [Renoprotective effects of statins under the conditions of acute renal failure, caused by rhabdomyolysis]. Zamorskiĭ II; Zeleniuk VG Biofizika; 2014; 59(5):1027-30. PubMed ID: 25730990 [TBL] [Abstract][Full Text] [Related]
3. Safety of lovastatin/extended release niacin compared with lovastatin alone, atorvastatin alone, pravastatin alone, and simvastatin alone (from the United States Food and Drug Administration adverse event reporting system). Alsheikh-Ali AA; Karas RH Am J Cardiol; 2007 Feb; 99(3):379-81. PubMed ID: 17261402 [TBL] [Abstract][Full Text] [Related]
4. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins. Haendeler J; Hoffmann J; Zeiher AM; Dimmeler S Circulation; 2004 Aug; 110(7):856-61. PubMed ID: 15289372 [TBL] [Abstract][Full Text] [Related]
5. Effects of statins on renal sodium and water handling: acute and short-term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans. Paulsen L; Holm C; Bech JN; Starklint J; Pedersen EB Nephrol Dial Transplant; 2008 May; 23(5):1556-61. PubMed ID: 18065809 [TBL] [Abstract][Full Text] [Related]
6. HMG-CoA reductase inhibitors and renal function. Campese VM; Park J Clin J Am Soc Nephrol; 2007 Nov; 2(6):1100-3. PubMed ID: 17942762 [No Abstract] [Full Text] [Related]
7. HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statins. Dansette PM; Jaoen M; Pons C Exp Toxicol Pathol; 2000 May; 52(2):145-8. PubMed ID: 10965989 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion. Turner NA; Midgley L; O'Regan DJ; Porter KE J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315 [TBL] [Abstract][Full Text] [Related]
10. In vitro effect of statins on cytokine production and mitogen response of human peripheral blood mononuclear cells. Bessler H; Salman H; Bergman M; Straussberg R; Djaldetti M Clin Immunol; 2005 Oct; 117(1):73-7. PubMed ID: 16051523 [TBL] [Abstract][Full Text] [Related]
11. On the factors modulating the effect of statins on malignant cell proliferation. Bessler H; Salman H; Bergman M; Djaldetti M Cancer Invest; 2007 Aug; 25(5):279-84. PubMed ID: 17661201 [TBL] [Abstract][Full Text] [Related]
12. Rhabdomyolysis following co-prescription of fusidic acid and atorvastatin. Teckchandani S; Robertson S; Almond A; Donaldson K; Isles C J R Coll Physicians Edinb; 2010 Mar; 40(1):33-6. PubMed ID: 21125037 [TBL] [Abstract][Full Text] [Related]
13. Renal effects of HMG-CoA reductase inhibition in a rat model of chronic inhibition of nitric oxide synthesis. Lecian D; Demova H; Lodererova A; Zdychova J; Kluckova H; Teplan V; Voska L; Komers R Kidney Blood Press Res; 2006; 29(3):135-43. PubMed ID: 16899993 [TBL] [Abstract][Full Text] [Related]
15. Acute effects of atorvastatin on glomerular filtration rate, tubular function, blood pressure, and vasoactive hormones in patients with type 2 diabetes. Paulsen L; Matthesen SK; Bech JN; Starklint J; Pedersen EB J Clin Pharmacol; 2010 Jul; 50(7):816-22. PubMed ID: 20056802 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacology of HMG CoA reductase inhibitors (statins)]. Kostner GM Wien Med Wochenschr; 1999; 149(5-6):120-4. PubMed ID: 10408002 [TBL] [Abstract][Full Text] [Related]
17. [Statins: similarities and differences in the pharmacological, clinical and laboratory aspects]. Motti C; Gnasso A; Cortese C Ann Ital Med Int; 2000; 15(1):96-102. PubMed ID: 10842898 [TBL] [Abstract][Full Text] [Related]
19. Analysis of five HMG-CoA reductase inhibitors-- atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies. Pasha MK; Muzeeb S; Basha SJ; Shashikumar D; Mullangi R; Srinivas NR Biomed Chromatogr; 2006 Mar; 20(3):282-93. PubMed ID: 16143964 [TBL] [Abstract][Full Text] [Related]
20. Pleiotropic effects of statins in atherosclerosis and diabetes. Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]